Equity Analysis /
India

IN : Healthcare - Overall - 4QFY21F result preview

    Rahul Agarwal
    Shubham Aggarwal
    CGS-CIMB
    16 April 2021
    Published by

    Base business patient volume recovery would re-confirm FY22-23F estimates. Expect sharp pick-up in antibody testing; EBITDA margins to normalise qoq. Retain Underweight. Lighten positions in the current COVID-19 relapse rally.